United States · FDA National Drug Code directory
RABEPRAZOLE SODIUM
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72888-059_4844a51a-513a-8b72-e063-6294a90ab996
- Product NDC
- 72888-059
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- rabeprazole sodium
- Labeler
- Advagen Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170601
- Source listing expiry
- 20271231
Source-listed ingredients
- RABEPRAZOLE SODIUM — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-30) · 72888-059-30
- 90 TABLET, DELAYED RELEASE in 1 BOTTLE (72888-059-90) · 72888-059-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →